Format
Sort by

Send to

Choose Destination

Search results

Items: 15

1.

Response to "Comment on 'Medical physicist assistants are a bad idea'‚ÄČ" [Med. Phys. 43, 1-3 (2016)].

Ezzell GA.

Med Phys. 2016 Jul;43(7):4463. doi: 10.1118/1.4954007. No abstract available.

PMID:
27370164
2.

Robustness quantification methods comparison in volumetric modulated arc therapy to treat head and neck cancer.

Liu W, Patel SH, Shen JJ, Hu Y, Harrington DP, Ding X, Halyard MY, Schild SE, Wong WW, Ezzell GA, Bues M.

Pract Radiat Oncol. 2016 Feb 13. pii: S1879-8500(16)00051-5. doi: 10.1016/j.prro.2016.02.002. [Epub ahead of print]

PMID:
27025166
3.

Medical physicist assistants are a bad idea.

Fontenla DP, Ezzell GA.

Med Phys. 2016 Jan;43(1):1. doi: 10.1118/1.4937596. No abstract available.

4.

RO-ILS: Radiation Oncology Incident Learning System: A report from the first year of experience.

Hoopes DJ, Dicker AP, Eads NL, Ezzell GA, Fraass BA, Kwiatkowski TM, Lash K, Patton GA, Piotrowski T, Tomlinson C, Ford EC.

Pract Radiat Oncol. 2015 Sep-Oct;5(5):312-8. doi: 10.1016/j.prro.2015.06.009. Epub 2015 Jun 25.

PMID:
26362705
5.

An improvement in IMRT QA results and beam matching in linacs using statistical process control.

Gagneur JD, Ezzell GA.

J Appl Clin Med Phys. 2014 Sep 8;15(5):4927. doi: 10.1120/jacmp.v15i5.4927.

PMID:
25207579
6.

Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.

Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.

J Urol. 2013 Aug;190(2):521-6. doi: 10.1016/j.juro.2013.02.012. Epub 2013 Feb 13.

PMID:
23415964
7.

The clinical case for proton beam therapy.

Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB.

Radiat Oncol. 2012 Oct 22;7:174. doi: 10.1186/1748-717X-7-174. Review.

8.

Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging.

Wong WW, Schild SE, Vora SA, Ezzell GA, Nguyen BD, Ram PC, Roarke MC.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e423-9. doi: 10.1016/j.ijrobp.2011.01.048. Epub 2011 Apr 7.

PMID:
21477947
9.

IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119.

Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, Molineu A, Palta JR, Ramsey CR, Salter BJ, Shi J, Xia P, Yue NJ, Xiao Y.

Med Phys. 2009 Nov;36(11):5359-73.

10.

Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.

Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.

Cancer. 2009 Dec 1;115(23):5596-606. doi: 10.1002/cncr.24558.

11.
12.
13.

Treatment planning for dose escalation in non-small cell lung cancer (NSCLC).

Schild SE, Korte SM, Wong WW, Vora SA, Younggren JA, Ezzell GA.

Med Dosim. 2004 Fall;29(3):196-203.

PMID:
15324916
14.

Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee.

Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, Xia P, Xiao Y, Xing L, Yu CX; IMRT subcommitte; AAPM Radiation Therapy committee.

Med Phys. 2003 Aug;30(8):2089-115.

15.

Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy.

Serago CF, Chungbin SJ, Buskirk SJ, Ezzell GA, Collie AC, Vora SA.

Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1130-8.

PMID:
12128112
Items per page

Supplemental Content

Loading ...
Write to the Help Desk